Infigratinib is a pan FGFR kinase inhibitor, and is an orally bioavailable pan inhibitor of human fibroblast growth factor receptors (FGFRs) with potential antiangiogenic and antineoplastic activities.
Molecular Weight:
560.5
Purity:
99% (HPLC)
CAS Number:
[872511-34-7]
Formula:
C26H31CI2N7O3
Target:
FGF receptor
* VAT and and shipping costs not included. Errors and price changes excepted